Evolution of the Average Target: Rollins, Inc.

Evolution of the Target Price: Rollins, Inc.

Changes in Analyst Recommendations: Rollins, Inc.

54a59d4b7219a1209bb8d903685.Oj6a612H16qBTKyAicvLyx-AI_lfqhoXHX_x0jd3Pe0.eF3tjjDykuLHI_vBz4CunmrGdKs69VZgSzqBtmcSSr1ofc6FH-uCzLIK6Q~619ac0c240d5efe5e3712bf01d526504
06-04 Rollins' Q2 Organic Growth, Margins to Accelerate Despite Higher Fuel Costs, RBC Says MT
05-29 Bernstein Downgrades Rollins to Market Perform From Outperform, Adjusts PT to $52 From $70 MT
05-29 Analyst recommendations: Best Buy, Caesars Entertainment, Dell, Dollar Tree, Okta… Zonebourse
05-15 Rollins' Medium-Term Outlook Backed by Pricing, Recurring Revenue, Acquisitions, RBC Says MT
05-15 Wells Fargo Adjusts Price Target on Rollins to $55 From $58, Maintains Equalweight Rating MT
05-13 Rollins Seen Reaffirming 2026 Outlook on Pricing Power, Customer Growth, RBC Says MT
04-27 Rothschild & Co Redburn Upgrades Rollins to Buy From Neutral, Adjusts PT to $66 From $51.90 MT
04-24 UBS Adjusts Price Target on Rollins to $61 From $58, Maintains Neutral Rating MT
04-24 Jefferies Adjusts Price Target on Rollins to $68 From $66, Maintains Buy Rating MT
04-24 Goldman Sachs Adjusts Price Target on Rollins to $67 From $66, Maintains Buy Rating MT
04-24 Canaccord Genuity Adjusts Price Target on Rollins to $51 From $52, Maintains Hold Rating MT
04-24 Wells Fargo Lifts Price Target on Rollins to $58 From $56, Maintains Equalweight Rating MT
04-13 Loop Capital Initiates Rollins at Hold With $56 Price Target MT
04-10 Rollins Seen Facing Softer Q1 Growth on Weather Impact, UBS Says MT
04-10 UBS Adjusts Price Target on Rollins to $58 From $62, Maintains Neutral Rating MT
04-06 Rollins Faces Weather-Related Headwinds to Q1 Organic Growth, Margin Expansion, RBC Says MT
02-13 BNP Paribas Adjusts Price Target on Rollins to $63 From $65, Maintains Neutral Rating MT
02-12 Goldman Sachs Adjusts Price Target on Rollins to $66 From $64, Maintains Buy Rating MT
02-12 RBC Cuts Price Target on Rollins to $67 From $70, Keeps Outperform Rating MT
02-12 Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… Zonebourse
02-12 Wells Fargo Downgrades Rollins to Equalweight From Overweight, Adjusts Price Target to $56 From $68 MT
01-21 UBS Adjusts Rollins Price Target to $65 From $61, Maintains Neutral Rating MT
01-14 Wells Fargo Adjusts Rollins Price Target to $68 From $65, Maintains Overweight Rating MT
01-06 BNP Paribas Exane Initiates Rollins at Neutral With $65 Price Target MT
12-23 RBC Raises Price Target on Rollins to $70 From $62, Keeps Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+31.75%
+17.22%
Average +24.49%
Weighted average by Cap. +25.96%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.77USD
Average target price
62.94USD
Spread / Average Target
+31.75%
High Price Target
72.00USD
Spread / Highest target
+50.72%
Low Price Target
50.00USD
Spread / Lowest Target
+4.67%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Bernstein
Wells Fargo Securities
Rothschild & Co Redburn
UBS
Jefferies & Co.
Goldman Sachs
Canaccord Genuity
Loop Capital
BNP Paribas
RBC Capital Markets
BNP Paribas Exane
Morgan Stanley
Barclays
JPMorgan Chase
Piper Sandler
Argus
Redburn Atlantic
CFRA
Stifel Nicolaus
BofA Securities
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.77USD
Average target price
62.94USD
Spread / Average Target
+31.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ROL Stock
  4. Consensus Rollins, Inc.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!